Back to SYRE
EMERALD ADVISERS, LLC SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$50.8M
Q3 2026
Peak value
$50.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $20.8M |
| Q1 2026 | $30.9M |
| Q2 2026 | $50.4M |
| Q3 2026 | $50.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $50.8M | 571.0K | — | — |
| Q2 2026 | $50.4M | 567.4K | — | — |
| Q1 2026 | $30.9M | 613.4K | — | — |
| Q4 2025 | $20.8M | 636.1K | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M